Going up a dose on Wegovy: how that decision gets made

The Wegovy schedule is a framework, not a countdown

Every Wegovy pen is part of a planned titration. The standard path runs 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, with roughly four weeks at each level. You can read the full Wegovy dose schedule if you want a detailed look at what changes at each step. The four-week window matters because that is broadly how long it takes most people's systems to adjust, gut motility slows, appetite signals shift, and the side-effect burden usually eases.

The key phrase is «usually eases». If nausea, vomiting or persistent stomach discomfort is still making daily life difficult by week three or four, moving to the next dose is rarely the right move. Your prescriber will weigh whether your body has genuinely settled at the current level. If it hasn't, staying put (or in some cases stepping back) is a legitimate clinical response, not a failure. That point tends to get lost in the eagerness to get to a therapeutic maintenance dose, and it's worth being honest about your symptoms rather than underreporting them to speed things along.

Tolerability is the first test. Weight-loss progress is context, not the deciding criterion at the titration stage. The timing of dose increases on Wegovy covers this in more depth, including what your prescriber is actually looking for when they review you.

What a dose increase actually changes, and the side effects to expect

Each step up raises the amount of semaglutide circulating in your system. GLP-1 receptor agonists slow gastric emptying and reduce appetite signals from the brain; a higher dose intensifies both effects. That is why results tend to improve with titration, and why the same mechanisms that make the medicine effective also produce the most common side effects.

After going up a dose, nausea is the most frequently reported symptom. Loose stools, constipation, burping, indigestion and fatigue are all common, especially in the first week or two at the new level. NHS guidance on semaglutide notes these effects typically settle as the body adapts. Eating smaller meals, staying well hydrated, avoiding very fatty or spicy food, and not lying down immediately after eating all help. None of this is surprising, your gut is adjusting to a new signal strength.

Pancreatitis is rarer but serious. The MHRA highlighted acute pancreatitis as a known infrequent risk across GLP-1 medicines in a January 2026 Drug Safety Update. Severe, persistent stomach pain that radiates to the back (with or without vomiting) needs urgent medical attention. That applies at any dose, but the early weeks after an increase are when to be most alert. Report any suspected side effects using the MHRA's Yellow Card scheme.

The case for going slower than the schedule suggests

There is no prize for hitting 2.4mg in the minimum time. This is a point our prescribers raise regularly, because the pressure people put on themselves to «get to the real dose» can work against them. A slower titration (spending six or eight weeks at a step rather than four) is not an unusual clinical choice, particularly for people who are very sensitive to GI side effects or who have a lower body weight to begin with.

For context on what the final step from 1.7mg to 2.4mg looks like in practice, that page covers the specific transition many people find trickiest. Some find the jump from 1mg to 1.7mg harder than expected; others sail through the top of the schedule and find the earlier steps were the worst. It varies considerably.

If you are managing Wegovy costs alongside titration, the Wegovy price guide sets out what a full titration course typically involves financially. One transparent price at a service like ours covers the clinical review needed before any repeat or dose increase, no separate prescription fee, no hidden charge for an additional consultation.

When to raise a dose question with your prescriber

Going up a dose on Wegovy is a clinical conversation, not something to decide alone. The right moment to raise it is when you have been on the current dose for at least four weeks, side effects have settled to a manageable level, and you want to understand what the next step involves. If you are managing the treatment through our prescribing team, every repeat order is reviewed before dispatch, that review is the natural point to ask about titration.

If you started on Wegovy at one of the early doses and want a clear picture of what's ahead, the overview of Wegovy dose management is a useful reference. And if you're approaching the 0.5mg step specifically, the 0.25mg to 0.5mg transition page explains what to expect from that first increase, often where people first feel the medicine starting to work.

If you haven't yet started treatment or are considering switching to Wegovy from another option, a free consultation with a prescriber is the right starting point. There's no obligation, and the assessment covers your full medical history before any prescription is issued.

Speak to our prescribers, the consultation is free, and a named clinician reviews your information the same day.